Europe Coagulant Market Size & Outlook, 2023-2030
The coagulant market in Europe is expected to reach a projected revenue of US$ 4,997.6 million by 2030. A compound annual growth rate of 7.1% is expected of Europe coagulant market from 2024 to 2030.
Revenue, 2023 (US$M)
$3,098.3
Forecast, 2030 (US$M)
$4,997.6
CAGR, 2024 - 2030
7.1%
Report Coverage
Europe
Europe coagulant market highlights
- The Europe coagulant market generated a revenue of USD 3,098.3 million in 2023.
- The market is expected to grow at a CAGR of 7.1% from 2024 to 2030.
- In terms of segment, systemic coagulants was the largest revenue generating product in 2023.
- Systemic Coagulants is the most lucrative product segment registering the fastest growth during the forecast period.
Europe data book summary
| Market revenue in 2023 | USD 3,098.3 million |
| Market revenue in 2030 | USD 4,997.6 million |
| Growth rate | 7.1% (CAGR from 2023 to 2030) |
| Largest segment | Systemic coagulants |
| Fastest growing segment | Systemic Coagulants |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Systemic Coagulants |
| Key market players worldwide | Johnson & Johnson, Baxter International Inc, Pfizer Inc, Bristol-Myers Squibb Co, Sanofi SA, Bayer AG, Novo Nordisk A/S ADR, CSL Ltd, Octapharma AG, Grifols SA Ordinary Shares - Class A, Amgen Inc, Takeda Pharmaceutical Co Ltd |
Other key industry trends
- In terms of revenue, Europe region accounted for 29.6% of the global coagulant market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 4,200.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Coagulant Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Octapharma AG | View profile | 10001+ | Lachen, Schwyz, Switzerland, Europe | http://www.octapharma.com/en.html |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| CSL Ltd | View profile | 32000 | 655 Elizabeth Street, Melbourne, VIC, Australia, 3000 | https://www.csl.com |
| Grifols SA Ordinary Shares - Class A | View profile | 23737 | Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, Spain, 08174 | https://www.grifols.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
